Body Mass Index: An Unreliable Adiposity Indicator for Predicting Outcomes of Liver Transplantation Due to Hepatocellular Carcinoma

被引:0
作者
Czarnecka, Kinga [1 ]
Czarnecka, Paulina [1 ]
Tronina, Olga [1 ]
Baczkowska, Teresa [1 ]
Durlik, Magdalena [1 ]
机构
[1] Med Univ Warsaw, Dept Transplant Med Immunol Nephrol & Internal Dis, 59 Nowogrodzka St, PL-02006 Warsaw, Poland
来源
GASTROINTESTINAL DISORDERS | 2024年 / 6卷 / 03期
关键词
hepatocellular carcinoma; liver transplantation; obesity; body mass index; hepatocellular carcinoma recurrence; VISCERAL ADIPOSITY; HEPATIC RESECTION; RECURRENCE; OBESITY; IMPACT; RISK; MODEL;
D O I
10.3390/gidisord6030040
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Obesity is a well-documented risk factor for the development of hepatocellular carcinoma (HCC) in the general population. The applicability of these findings to liver recipients is uncertain, and the results of available data have not been unanimous. The objective of the current study was to investigate the impact of the pre-operative body mass index (BMI) on oncological outcomes of liver transplantation due to HCC. Methods: This observational retrospective study enrolled all patients with histologically confirmed HCC who underwent liver transplantation from a deceased donor in our centre between 2008 and 2018. Results: Overall, 83 patients were enrolled and were subsequently stratified according to their pre-operative BMI into three groups: patients with normal body weight (n = 53), patients with overweight (n = 23), patients with obesity (n = 7). Overall tumour recurrence was 12%. BMI failed to predict the 5-year recurrence-free survival (p = 0.55), risk of tumour recurrence (p = 0.314) and overall 5-year survival (p = 0.19) in liver recipients. Conclusions: BMI was proven to be an unreliable surrogate measure of obesity for predicting oncological outcomes among liver recipients. Other obesity indices should be referenced to assess cancer-related prognosis more accurately in these groups of patients.
引用
收藏
页码:607 / 621
页数:15
相关论文
共 51 条
  • [1] Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
    Amado, Victor
    Rodriguez-Peralvarez, Manuel
    Ferrin, Gustavo
    De la Mata, Manuel
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2019, 6 : 1 - 10
  • [2] Angin Y.S., 2024, J. Inonu Liver Transplant. Inst, P94, DOI [10.14744/jilti.2023.69885, DOI 10.14744/JILTI.2023.69885]
  • [3] The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma
    Bai, Dou-Sheng
    Zhang, Chi
    Chen, Ping
    Jin, Sheng-Jie
    Jiang, Guo-Qing
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [4] Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults
    Bhaskaran, Krishnan
    Douglas, Ian
    Forbes, Harriet
    dos-Santos-Silva, Isabel
    Leon, David A.
    Smeeth, Liam
    [J]. LANCET, 2014, 384 (9945) : 755 - 765
  • [5] Artificial intelligence, machine learning, and deep learning in liver transplantation
    Bhat, Mamatha
    Rabindranath, Madhumitha
    Chara, Beatriz Sordi
    Simonetto, Douglas A.
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 (06) : 1216 - 1233
  • [6] Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation Impact of Treatment Modality and Recurrence Characteristics
    Bodzin, Adam S.
    Lunsford, Keri E.
    Markovic, Daniela
    Harlander-Locke, Michael P.
    Busuttil, Ronald W.
    Agopian, Vatche G.
    [J]. ANNALS OF SURGERY, 2017, 266 (01) : 118 - 125
  • [7] Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Bray, Freddie
    Laversanne, Mathieu
    Sung, Hyuna
    Ferlay, Jacques
    Siegel, Rebecca L.
    Soerjomataram, Isabelle
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (03) : 229 - 263
  • [8] Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma
    Calderaro, Julien
    Seraphin, Tobias Paul
    Luedde, Tom
    Simon, Tracey G.
    [J]. JOURNAL OF HEPATOLOGY, 2022, 76 (06) : 1348 - 1361
  • [9] Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
    Clavien, Pierre-Alain
    Lesurtel, Mickael
    Bossuyt, Patrick M. M.
    Gores, Gregory J.
    Langer, Bernard
    Perrier, Arnaud
    [J]. LANCET ONCOLOGY, 2012, 13 (01) : E11 - E22
  • [10] Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review
    de'Angelis, Nicola
    Landi, Filippo
    Carra, Maria Clotilde
    Azoulay, Daniel
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (39) : 11185 - 11198